ALANAZI, M., PATHAN, A. A., ABDULJALEEL, Z., SHAIK, J. P., ALABDULKARIM, H. A., SEMLALI, A., BAZZI, M. D. & PARINE, N. R. 2013. Association between PARP-1 V762A polymorphism and breast cancer susceptibility in Saudi population. PLoS One, 8, e85541.
ASPORD, C., PEDROZA-GONZALEZ, A., GALLEGOS, M., TINDLE, S., BURTON, E. C., SU, D., MARCHES, F., BANCHEREAU, J. & PALUCKA, A. K. 2007. Breast cancer instructs dendritic cells to prime interleukin 13-secreting CD4+ T cells that facilitate tumor development. J Exp Med, 204, 1037-47.
CHENG, J., RANDALL, A. & BALDI, P. 2006. Prediction of protein stability changes for single-site mutations using support vector machines. Proteins, 62, 1125-32.
CORREN, J. & ZIEGLER, S. F. 2019. TSLP: from allergy to cancer. Nat Immunol, 20, 1603-1609.
DE MONTE, L., RENI, M., TASSI, E., CLAVENNA, D., PAPA, I., RECALDE, H., BRAGA, M., DI CARLO, V., DOGLIONI, C. & PROTTI, M. P. 2011. Intratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphopoietin production and reduced survival in pancreatic cancer. J Exp Med, 208, 469-78.
DURUM, S. K. 2014. IL-7 and TSLP receptors: twisted sisters. Blood, 124, 4-5.
ERDMANN, R. B., GARTNER, J. G., LEONARD, W. J. & ELLISON, C. A. 2013. Lack of functional TSLP receptors mitigates Th2 polarization and the establishment and growth of 4T1 primary breast tumours but has different effects on tumour quantities in the lung and brain. Scand J Immunol, 78, 408-18.
GAO, P. S., RAFAELS, N. M., MU, D., HAND, T., MURRAY, T., BOGUNIEWICZ, M., HATA, T., SCHNEIDER, L., HANIFIN, J. M., GALLO, R. L., GAO, L., BEATY, T. H., BECK, L. A., LEUNG, D. Y. & BARNES, K. C. 2010. Genetic variants in thymic stromal lymphopoietin are associated with atopic dermatitis and eczema herpeticum. J Allergy Clin Immunol, 125, 1403-1407 e4.
GHIRELLI, C., SADACCA, B., REYAL, F., ZOLLINGER, R., MICHEA, P., SIRVEN, P., PATTARINI, L., MARTINEZ-CINGOLANI, C., GUILLOT-DELOST, M., NICOLAS, A., SCHOLER-DAHIREL, A. & SOUMELIS, V. 2016. No evidence for TSLP pathway activity in human breast cancer. Oncoimmunology, 5, e1178438.
HISCOX, S., DAVIES, E. L. & BARRETT-LEE, P. 2009. Aromatase inhibitors in breast cancer. Maturitas, 63, 275-9.
JIA, M., WANG, Z. J., ZHAO, H. Z., SHEN, H. P., CHENG, Y. P., LUO, Z. B. & TANG, Y. M. 2015. Prognostic significance of cytokine receptor-like factor 2 alterations in acute lymphoblastic leukemia: a meta-analysis. World J Pediatr, 11, 126-33.
KEARSE, M., MOIR, R., WILSON, A., STONES-HAVAS, S., CHEUNG, M., STURROCK, S., BUXTON, S., COOPER, A., MARKOWITZ, S., DURAN, C., THIERER, T., ASHTON, B., MEINTJES, P. & DRUMMOND, A. 2012. Geneious Basic: an integrated and extendable desktop software platform for the organization and analysis of sequence data. Bioinformatics, 28, 1647-9.
LO KUAN, E. & ZIEGLER, S. F. 2014. Thymic stromal lymphopoietin and cancer. J Immunol, 193, 4283-8.
LOOSE, D. & VAN DE WIELE, C. 2009. The immune system and cancer. Cancer Biother Radiopharm, 24, 369-76.
MACFARLANE, T. V., SEAGER, A. L., MOLLER, M., MORGAN, G. & THORNTON, C. A. 2010. Thymic stromal lymphopoietin is present in human breast milk. Pediatr Allergy Immunol, 21, e454-6.
OLKHANUD, P. B., ROCHMAN, Y., BODOGAI, M., MALCHINKHUU, E., WEJKSZA, K., XU, M., GRESS, R. E., HESDORFFER, C., LEONARD, W. J. & BIRAGYN, A. 2011. Thymic stromal lymphopoietin is a key mediator of breast cancer progression. J Immunol, 186, 5656-62.
PANDEY, A., OZAKI, K., BAUMANN, H., LEVIN, S. D., PUEL, A., FARR, A. G., ZIEGLER, S. F., LEONARD, W. J. & LODISH, H. F. 2000. Cloning of a receptor subunit required for signaling by thymic stromal lymphopoietin. Nat Immunol, 1, 59-64.
PARK, L. S., MARTIN, U., GARKA, K., GLINIAK, B., DI SANTO, J. P., MULLER, W., LARGAESPADA, D. A., COPELAND, N. G., JENKINS, N. A., FARR, A. G., ZIEGLER, S. F., MORRISSEY, P. J., PAXTON, R. & SIMS, J. E. 2000. Cloning of the murine thymic stromal lymphopoietin (TSLP) receptor: Formation of a functional heteromeric complex requires interleukin 7 receptor. J Exp Med, 192, 659-70.
PEDROZA-GONZALEZ, A., XU, K., WU, T. C., ASPORD, C., TINDLE, S., MARCHES, F., GALLEGOS, M., BURTON, E. C., SAVINO, D., HORI, T., TANAKA, Y., ZURAWSKI, S., ZURAWSKI, G., BOVER, L., LIU, Y. J., BANCHEREAU, J. & PALUCKA, A. K. 2011. Thymic stromal lymphopoietin fosters human breast tumor growth by promoting type 2 inflammation. J Exp Med, 208, 479-90.
PROTTI, M. P. & DE MONTE, L. 2012. Cross-talk within the tumor microenvironment mediates Th2-type inflammation in pancreatic cancer. Oncoimmunology, 1, 89-91.
RECHE, P. A., SOUMELIS, V., GORMAN, D. M., CLIFFORD, T., LIU, M., TRAVIS, M., ZURAWSKI, S. M., JOHNSTON, J., LIU, Y. J., SPITS, H., DE WAAL MALEFYT, R., KASTELEIN, R. A. & BAZAN, J. F. 2001. Human thymic stromal lymphopoietin preferentially stimulates myeloid cells. J Immunol, 167, 336-43.
REDHU, N. S. & GOUNNI, A. S. 2012. Function and mechanisms of TSLP/TSLPR complex in asthma and COPD. Clin Exp Allergy, 42, 994-1005.
REN, X., WANG, L. & WU, X. 2016. A potential link between TSLP/TSLPR/STAT5 and TLR2/MyD88/NFkappaB-p65 in human corneal epithelial cells for Aspergillus fumigatus tolerance. Mol Immunol, 71, 98-106.
SANTEN, R. J., BRODIE, H., SIMPSON, E. R., SIITERI, P. K. & BRODIE, A. 2009. History of aromatase: saga of an important biological mediator and therapeutic target. Endocr Rev, 30, 343-75.
SEBASTIAN, K., BOROWSKI, A., KUEPPER, M. & FRIEDRICH, K. 2008. Signal transduction around thymic stromal lymphopoietin (TSLP) in atopic asthma. Cell Commun Signal, 6, 5.
SEMLALI, A., AL AMRI, A., AZZI, A., AL SHAHRANI, O., ARAFAH, M., KOHAILAN, M., ALJEBREEN, A. M., ALHARBI, O., ALMADI, M. A., AZZAM, N. A., PARINE, N. R., ROUABHIA, M. & ALANAZI, M. S. 2015. Expression and new exon mutations of the human Beta defensins and their association on colon cancer development. PLoS One, 10, e0126868.
SEMLALI, A., ALMUTAIRI, M., AZZI, A., REDDY PARINE, N., ALAMRI, A., ALSULAMI, S., MESHAL ALUMRI, T., SAUD ALANAZI, M. & ROUABHIA, M. 2019a. TSLP and TSLP receptors variants are associated with smoking. Mol Genet Genomic Med, 7, e842.
SEMLALI, A., ALMUTAIRI, M., REDDY PARINE, N., AL AMRI, A., ALMEER, R., ALANAZI, M. S. & ROUABHIA, M. 2019b. Expression and allele frequencies of Thymic stromal lymphopoietin are a key factor of breast cancer risk. Mol Genet Genomic Med, 7, e813.
SEMLALI, A., JACQUES, E., KOUSSIH, L., GOUNNI, A. S. & CHAKIR, J. 2010. Thymic stromal lymphopoietin-induced human asthmatic airway epithelial cell proliferation through an IL-13-dependent pathway. J Allergy Clin Immunol, 125, 844-50.
SEMLALI, A., JALOULI, M., PARINE, N. R., AL AMRI, A., ARAFAH, M., AL NAEEM, A., ABDULLAH AJAJ, S., ROUABHIA, M. & ALANAZI, M. S. 2017a. Toll-like receptor 4 as a predictor of clinical outcomes of estrogen receptor-negative breast cancer in Saudi women. Onco Targets Ther, 10, 1207-1216.
SEMLALI, A., PARINE, N. R., AL AMRI, A., AZZI, A., ARAFAH, M., KOHAILAN, M., SHAIK, J. P., ALMADI, M. A., ALJEBREEN, A. M., ALHARBI, O., ALI AZZAM, N., ROUABHIA, M. & ALANAZI, M. S. 2017b. Association between TLR-9 polymorphisms and colon cancer susceptibility in Saudi Arabian female patients. Onco Targets Ther, 10, 1-11.
SEMLALI, A., REDDY PARINE, N., ARAFAH, M., MANSOUR, L., AZZI, A., AL SHAHRANI, O., AL AMRI, A., SHAIK, J. P., ALJEBREEN, A. M., ALHARBI, O., ALMADI, M. A., AZZAM, N. A., KOHAILAN, M., ROUABHIA, M. & ALANAZI, M. S. 2016. Expression and Polymorphism of Toll-Like Receptor 4 and Effect on NF-kappaB Mediated Inflammation in Colon Cancer Patients. PLoS One, 11, e0146333.
SHAMIM, Z., MULLER, K., SVEJGAARD, A., POULSEN, L. K., BODTGER, U. & RYDER, L. P. 2007. Association between genetic polymorphisms in the human interleukin-7 receptor alpha-chain and inhalation allergy. Int J Immunogenet, 34, 149-51.
SHERRILL, J. D., GAO, P. S., STUCKE, E. M., BLANCHARD, C., COLLINS, M. H., PUTNAM, P. E., FRANCIOSI, J. P., KUSHNER, J. P., ABONIA, J. P., ASSA'AD, A. H., KOVACIC, M. B., BIAGINI MYERS, J. M., BOCHNER, B. S., HE, H., HERSHEY, G. K., MARTIN, L. J. & ROTHENBERG, M. E. 2010. Variants of thymic stromal lymphopoietin and its receptor associate with eosinophilic esophagitis. J Allergy Clin Immunol, 126, 160-5 e3.
SINHA, S., SINGH, J. & JINDAL, S. K. 2015. Association of interleukin 7 receptor (rs1494555 and rs6897932) gene polymorphisms with asthma in a north Indian population. Allergy Rhinol (Providence), 6, 168-76.
SOUMELIS, V., RECHE, P. A., KANZLER, H., YUAN, W., EDWARD, G., HOMEY, B., GILLIET, M., HO, S., ANTONENKO, S., LAUERMA, A., SMITH, K., GORMAN, D., ZURAWSKI, S., ABRAMS, J., MENON, S., MCCLANAHAN, T., DE WAAL-MALEFYT RD, R., BAZAN, F., KASTELEIN, R. A. & LIU, Y. J. 2002. Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat Immunol, 3, 673-80.
THORNTON, C. A. & MORGAN, G. 2009. Innate and adaptive immune pathways to tolerance. Nestle Nutr Workshop Ser Pediatr Program, 64, 45-57; discussion 57-61, 251-7.
TONOZUKA, Y., FUJIO, K., SUGIYAMA, T., NOSAKA, T., HIRAI, M. & KITAMURA, T. 2001. Molecular cloning of a human novel type I cytokine receptor related to delta1/TSLPR. Cytogenet Cell Genet, 93, 23-5.
VARRICCHI, G., PECORARO, A., MARONE, G., CRISCUOLO, G., SPADARO, G., GENOVESE, A. & MARONE, G. 2018. Thymic Stromal Lymphopoietin Isoforms, Inflammatory Disorders, and Cancer. Front Immunol, 9, 1595.
VERSTRAETE, K., PEELMAN, F., BRAUN, H., LOPEZ, J., VAN ROMPAEY, D., DANSERCOER, A., VANDENBERGHE, I., PAUWELS, K., TAVERNIER, J., LAMBRECHT, B. N., HAMMAD, H., DE WINTER, H., BEYAERT, R., LIPPENS, G. & SAVVIDES, S. N. 2017. Structure and antagonism of the receptor complex mediated by human TSLP in allergy and asthma. Nat Commun, 8, 14937.
XIE, F., MENG, Y. H., LIU, L. B., CHANG, K. K., LI, H., LI, M. Q. & LI, D. J. 2013. Cervical carcinoma cells stimulate the angiogenesis through TSLP promoting growth and activation of vascular endothelial cells. Am J Reprod Immunol, 70, 69-79.
YU, J. I., KANG, I. H., CHUN, S. W., YUN, K. J., MOON, H. B. & CHAE, S. C. 2010. Identifying the polymorphisms in the thymic stromal lymphopoietin receptor (TSLPR) and their association with asthma. BMB Rep, 43, 499-505.
YUE, W., LIN, Y., YANG, X., LI, B., LIU, J. & HE, R. 2016. Thymic stromal lymphopoietin (TSLP) inhibits human colon tumor growth by promoting apoptosis of tumor cells. Oncotarget, 7, 16840-54.
ZHANG, W., WANG, J., WANG, Q., CHEN, G., ZHANG, J., CHEN, T., WAN, T., ZHANG, Y. & CAO, X. 2001. Identification of a novel type I cytokine receptor CRL2 preferentially expressed by human dendritic cells and activated monocytes. Biochem Biophys Res Commun, 281, 878-83.
ZHENG, X., MA, P., DE PAIVA, C. S., CUNNINGHAM, M. A., HWANG, C. S., PFLUGFELDER, S. C. & LI, D. Q. 2010. TSLP and downstream molecules in experimental mouse allergic conjunctivitis. Invest Ophthalmol Vis Sci, 51, 3076-82.
ZHONG, J. & PANDEY, A. 2010. Site-directed mutagenesis reveals a unique requirement for tyrosine residues in IL-7Ralpha and TSLPR cytoplasmic domains in TSLP-dependent cell proliferation. BMC Immunol, 11, 5.
ZIEGLER, S. F. 2010. The role of thymic stromal lymphopoietin (TSLP) in allergic disorders. Curr Opin Immunol, 22, 795-9.